Multiple Myeloma Research and TreatmentsProtein Degradation and InhibitorsPeptidase Inhibition and AnalysisImmunotherapy and Immune ResponsesTesticular diseases and treatments
Publications
179
Citations
2,715
Est. group size
—
Recurring co-author estimate
Active years
30
Publishing since 1996
Publication cadence
Publications per year over the last 10 years — averaging 21.2/year recently
Recent publications
- High-Flow Congenital Arteriovenous Malformation of the Right Deltoid Muscle in a Pediatric Patient: A Case Report
Cureus · 2025
- Ischemic Stroke in Young Female Adults Caused by Carotid Webs: A Case Series From Rashid Hospital, Dubai
Cureus · 2025
- Internal Pudendal Artery Injury and Bleeding Into the Corpora Cavernosum Due to Complex Open Book Pelvic Fracture
Cureus · 2025
- Car Tracker with Parking System Using Machine Learning by RFID(Radio Frequency Identification)
International Journal for Research in Applied Science and Engineering Technology · 2025
- Identification of the Distinct Immune Microenvironment Features Associated with Progression Following High-Dose Melphalan and Autologous Stem Cell Transplant in Multiple Myeloma
Cancer Immunology Research · 2025
- Supplementary Table S1 from Identification of the Distinct Immune Microenvironment Features Associated with Progression Following High-Dose Melphalan and Autologous Stem Cell Transplant in Multiple Myeloma
2025
- Supplementary Figure S3 from Identification of the Distinct Immune Microenvironment Features Associated with Progression Following High-Dose Melphalan and Autologous Stem Cell Transplant in Multiple Myeloma
2025
- Figure 3 from Identification of the Distinct Immune Microenvironment Features Associated with Progression Following High-Dose Melphalan and Autologous Stem Cell Transplant in Multiple Myeloma
2025
- Supplementary Table S3 from Identification of the Distinct Immune Microenvironment Features Associated with Progression Following High-Dose Melphalan and Autologous Stem Cell Transplant in Multiple Myeloma
2025
- Data from Identification of the Distinct Immune Microenvironment Features Associated with Progression Following High-Dose Melphalan and Autologous Stem Cell Transplant in Multiple Myeloma
2025
- Figure 2 from Identification of the Distinct Immune Microenvironment Features Associated with Progression Following High-Dose Melphalan and Autologous Stem Cell Transplant in Multiple Myeloma
2025
- Figure 6 from Identification of the Distinct Immune Microenvironment Features Associated with Progression Following High-Dose Melphalan and Autologous Stem Cell Transplant in Multiple Myeloma
2025
- Supplementary Table S2 from Identification of the Distinct Immune Microenvironment Features Associated with Progression Following High-Dose Melphalan and Autologous Stem Cell Transplant in Multiple Myeloma
2025
- Supplementary Table S4 from Identification of the Distinct Immune Microenvironment Features Associated with Progression Following High-Dose Melphalan and Autologous Stem Cell Transplant in Multiple Myeloma
2025
- Supplementary Table S5 from Identification of the Distinct Immune Microenvironment Features Associated with Progression Following High-Dose Melphalan and Autologous Stem Cell Transplant in Multiple Myeloma
2025
Publishes in
- Blood×7
- Biology of Blood and Marrow Transplantation×5
- Figshare×5
- Journal of Clinical Oncology×4
- Research Square×4
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 9, 2026.
Claim or correct this profile